According to the healthcare IT market research firm KLAS, adopting structured reporting is top of mind in the cardiovascular information system (CVIS, or cardiac PACS) market space, but moving the needle has proven difficult. Even when organizations have expanded their deployment of structured reporting, clinician adoption has not always followed. KLAS said a common reason for this is because end-user clinicians are dissatisfied with their system.


April 30, 2020 — A large study in adolescents and children, some as young as 3 years of age, shows a link between obesity, high blood pressure, and later damage to blood vessels.


The biggest trend across healthcare the past two years is the emergence of artificial intelligence (AI) and its integration into numerous cardiac ultrasound systems from several vendors. The current AI-enabled echocardiography systems help speed workflow by auto identifying the cardiac anatomy, creating automated quantification, automated ejection fractions and mitral valve regurgitation PISA scores, and the ability to view 3-D datasets and pull out the optimal views for auto measurements to eliminate inter-operator variability. 


This is a human cadaver heart being examined by a high school student as part of a science education program offered by the Cardiovascular Research Foundation (CRF) at its annual Transcatheter Cardiovascular Therapeutics (TCT) interventional cardiology meeting. Each year, TCT has the Hands on Hearts exhibit, where cardiologists can look at specimens showing various cardiac disease states or implanted devices. 

May 1, 2020 — The Heart Rhythm Society (HRS) has created a COVID-19 Task Force to make recommendations related to education, training, certification and procedural participation during the pandemic. HRS said the COVID-19 pandemic has significantly impacted medical training in clinical cardiac electrophysiology (CCEP). Elective procedures in most centers have been deferred, significantly impacting the opportunity for fellows to assist in procedures.

April 23, 2020 — A special report published in the journal Radiology outlines prevention, diagnosis and treatment of complications stemming from blood clots in patients with COVID-19.[1] The journal also published two research letters and a case study on this topic.


April 23, 2020 — The U.S. Food and Drug Administration (FDA) issued a Drug Safety Communication today reminding doctors there are serious side effects when using hydroxychloroquine and chloroquine in the off-label use to treat COVID-19 patients. This includes potentially life-threatening heart rhythm problems. 


April 24, 2020 — AliveCor and Omron Healthcare announced a global, strategic alliance that combines AliveCor's mobile device ECG technology with blood pressure devices from Omron to better serve customers and expand access to remote patient care. This partnership aligns with global trends to deploy noninvasive remote monitoring devices to facilitate patient monitoring while reducing patient and healthcare provider contact during the current pandemic.

April 24, 2020 — The U.S. Food and Drug Administration (FDA) has lifted its injunction prohibiting the manufacturing and shipping of external defibrillators for the United States. 

April 23, 2020 – LivaNova PLC said the U.S. Food and Drug Administration (FDA) is now permitting the company to expand its indicated use of extracorporeal membrane oxygenation (ECMO) therapy for longer than six hours. This is allowed under FDA guidance issued April 6 to temporarily expand the availability of devices to address the novel coronavirus (COVID-19, SARS-CoV-2) pandemic.

Subscribe Now